Showing all 3 results
-
Mounjaro
$170.00Mounjaro (Tirzepatide) is a breakthrough once-weekly weight loss injection that combines dual GIP and GLP-1 receptor agonist action. Clinical studies show average weight loss of 15-22.5% when combined with diet and exercise, making it one of the most effective prescription weight loss medications available.
-
Wegovy
$210.00Wegovy (Semaglutide 2.4mg) is an FDA-approved once-weekly weight loss injection that helps adults lose 15% or more of their body weight. This GLP-1 receptor agonist reduces appetite, increases fullness, and supports sustainable weight management when combined with diet and exercise.
-
Zepbound
$200.00Zepbound (Tirzepatide) is a powerful dual GIP/GLP-1 receptor agonist approved for chronic weight management. Clinical studies show average weight loss of 15-20.9% when combined with diet and exercise, offering superior results for adults with obesity or weight-related health conditions.
